MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4874 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-01-25 (reporterosdelsur.com.mx)
Are you investing into the future? Don't miss these AI medical actions! -
Discovering insights in Medtronic and AI Revolution in health care Investments in the health care sector have increased, especially after Covid-19, when artificial intelligence (AI) becomes a transformation force. The health care market based on AI, recently priced at $ 11 billion, according to forecasts, is to increase rapidly to $ 188 billion by 2030, which indicates a significant change in the method of providing medical services. Outstanding characters from the technology industry, including co -founder of Oracle, emphasized the key role of AI in such areas as early cancer detection and vaccine innovations. AI's ability to analyze huge health data collections is conducive to faster and more accurate medical decisions, which is significantly
Read more
2025-01-22 (startribune.com)
Thierry Piéton will step in as Medtronic CFO in March
Thierry Piéton, 54, replaces Gary Corona, who has served as interim CFO since Karen Parkhill resigned last summer. Parkhill oversaw restructuring at Medtronic as the company faced financial challenges such as a steep drop in net income.
Read more
2025-01-22 (globalbankingandfinance.com)
Medtronic appoints Renault's exec Thierry Piéton as finance chief
(Reuters) - Medtronic said on Monday it will appoint Renault's finance chief Thierry Piéton as its Chief Financial Officer, effective March 3. Piéton will succeed Gary Corona, who has been serving as
Read more
2025-01-10 (sphericalinsights.com)
Global Gelfoam Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Absorbable Gelatin Sponge, Gelatin Powder, Gelatin Foam), By Application (Surgical Hemostasis, Wound Care, Dental Procedures, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033
The Global Gelfoam Market Size is anticipated to USD 2.39 billion by 2033, at a CAGR of 8.68% .Segments are ,By Product Type, By Application
Read more
2024-10-08 (globenewswire.com)
Remote Patient Monitoring Market Research 2024: Focused Insights 2023-2029 with Exclusive Data on 49 Vendors Including Medtronic, Philips, ResMed, AMD, GE, Teladoc Health, & Vivify Health
Dublin, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The "Remote Patient Monitoring Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.
Read more
2024-08-30 (acc.org)
Cover Story | Renal Denervation: Expanding Care For Treatment-Resistant Hypertension - American College of Cardiology
Hypertension remains the leading global cause of death and disability, with more than half of hypertensive individuals in the U.S. failing to meet guideline-directed blood pressure (BP) targets. This scenario underscores a significant public health challenge driven by factors such as patient nonadherence, physician inertia and complex polypharmacy regimens. Against this backdrop, catheter-based renal denervation (RDN) has emerged as a novel interventional strategy for the management of treatment-resistant hypertension.
Read more
2024-08-21 (investing.com)
Earnings call: Medtronic reports revenue growth of 5.3% By Investing.com
Earnings call: Medtronic reports revenue growth of 5.3%
Read more
2024-08-07 (csrwire.com)
Medtronic: Technology Bias Is Real. Here’s What We’re Doing To Fix It
Doctors have used pulse oximeters for more than 40 years, but the pandemic put the devices in the spotlight after studies found they may not be accurate across all skin tones.
Read more
2024-07-24 (mexicobusiness.news)
Medical Devices Sector Cuts 14,000 Jobs Amid Ongoing Challenges
Medical devices firms cut over 14,000 jobs in 18 months due to restructuring and reduced COVID-19 testing demand, with layoffs peaking mid-2023.
Read more